MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Orthostatic hypotension in early onset Parkinson’s disease

    Z. Liu, D.N Su, J.H Zhou, T. Feng (Beijing, China)

    Objective: To investigate Orthostatic hypotension (OH)  feature in early onset Parkinson's disease (EOPD)  , especially delayed OH and acute OH post drug.  To explore OH…
  • MDS Virtual Congress 2020

    The effect of exercise on pain in Parkinson’s disease: A protocol for a systematic review

    V. Nguy, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

    Objective: To perform and present a systematic review assessing the effects of exercise on pain in people with Parkinson’s disease (PD) (prospero registration CRD42019129154). Background:…
  • MDS Virtual Congress 2020

    Association between essential tremor, constipation, and the risk of developing Parkinson’s disease

    C. Reynolds, M. Gupta, M. Sandulescu (Danville, PA, USA)

    Objective: To evaluate the association between constipation and the risk of Parkinson’s disease (PD) in patients with a prior history of essential tremor (ET). Background:…
  • MDS Virtual Congress 2020

    Odor Identification as a Biomarker of Incident Cognitive Impairment and its Correlation with Neuropathology in the Rush MAP

    J. Toledo, J. Schneider, L. Chanine, S. Nag, R. Akhtar, A. Buchman, J. Trojanowski, D. Bennett (Houston, TX, USA)

    Objective: Evaluate the neuropathological correlates and prospective incident cognitive and motor changes associated with odor identification (OI) in cognitively normal (CN) subjects. Background: Hyposmia is…
  • MDS Virtual Congress 2020

    Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease

    J. Behnke, L. Rauschenberger, S. Knorr, J. Volkmann, C.W Ip (Wuerzburg, Germany)

    Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…
  • MDS Virtual Congress 2020

    Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients

    L. Neilson, J. Baird, B. Lobb, H. Vanderjagt, N. Gray, S. O'Connor, J. Quinn (Portland, OR, USA)

    Objective: To evaluate the sensitivity of instrumented measures of motor dysfunction and candidate serological markers of disease to predict disease progression in de novo Parkinson’s…
  • MDS Virtual Congress 2020

    Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus

    H. Bejr-kasem, J. Pagonabarraga, F. Sampedro, S. Martínez-Horta, R. Perez-Gonzalez, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, A. Campolongo, C. Izquierdo, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…
  • MDS Virtual Congress 2020

    Depression in patients with Parkinson’s disease

    M. Lisak, B. Špiljak (Zagreb, Croatia)

    Objective: The objective of this study was to correlate PD severity with depression. Background: ​​​​Depression is the most common psychiatric disorder in patients with PD. In…
  • MDS Virtual Congress 2020

    Donepezil for mild cognitive impairment in Parkinson’s disease: A 48-week follow-up study

    K. Baik, S. Kim, S. Kang, Y. Sohn, P. Lee, S. Kang (Seoul, Republic of Korea)

    Objective: To investigate the efficacy of donepezil for mild cognitive impairment (MCI) in Parkinson’s disease (PD). Background: MCI is common in PD. The mechanism of…
  • MDS Virtual Congress 2020

    Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact on Impulse Control Disorders

    A. Espay, K. Markopoulou, P. Bhargava, B. Navia (Cincinnati, OH, USA)

    Objective: Evaluate effect of apomorphine sublingual film (APL-130277; APL) on impulse control disorders (ICD) in patients with Parkinson’s disease (PD) and “OFF” episodes. Background: In…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley